Cargando…

Activated protein C in sepsis: an Indian experience

Detalles Bibliográficos
Autores principales:	Abraham, B, Mohan, M, Raja, J, Ramakrishnan, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098345/ http://dx.doi.org/10.1186/cc3258

Ejemplares similares

Serum cholesterol level: is it a marker of sepsis?
por: Abraham, B, et al.
Publicado: (2005)

Management of sepsis in Indian ICUs: Indian data from the MOSAICS study
por: Divatia, J
Publicado: (2012)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, L, et al.
Publicado: (2009)

Testing of anti-activated protein C antibodies in four drotrecogin alfa (activated) severe sepsis studies
por: Yan, S, et al.
Publicado: (2008)

Protein C in murine neonatal sepsis
por: Muchitsch, E, et al.
Publicado: (2005)

Activated protein C consumption and coagulation parameters in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
por: Mohamed, H, et al.
Publicado: (2007)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

C-reactive protein and hemogram parameters for the nonsepsis SIRS and sepsis: what do they mean?
por: Gucyetmez, B, et al.
Publicado: (2015)

First experiences with protein C concentrate in adult patients with severe sepsis and septic shock associated to low protein C levels: a dose-finding study
por: Baratto, F, et al.
Publicado: (2005)

De-escalation of empiric antibiotic therapy in sepsis - an indian observational study
por: Jakkinaboina, S, et al.
Publicado: (2015)

High C-reactive protein and low cholesterol levels are prognostic marker in severe sepsis
por: Memis, D, et al.
Publicado: (2006)

Severe protein C deficiency association with organ dysfunction and mortality in patients with severe sepsis
por: Vail, M, et al.
Publicado: (2007)

Significance of gain and loss of chromosomal abnormalities in AML: an Indian experience
por: Trivedi, Pina J, et al.
Publicado: (2014)

Serum C-reactive protein concentration in early abdominal and pulmonary sepsis
por: Orati, JA, et al.
Publicado: (2013)

Efficiency diagnostic and advantages of procalcitonin and C-reactive protein in the early diagnosis of sepsis
por: De la Torre-Prados, M, et al.
Publicado: (2010)

Role of procalcitonin and high-sensitivity C-reactive protein in sepsis: a prospective study
por: Das, S, et al.
Publicado: (2011)

C-reactive protein as an early marker of sepsis resolution: results from the Portuguese Community-acquired Sepsis Study (SACiUCI study)
por: Povoa, P, et al.
Publicado: (2011)

Serum C-reactive protein levels in patients with sepsis varies according to the site of infection
por: Lobo, S, et al.
Publicado: (2005)

Compliment activity patterns in patients with sepsis after human purified C1-esterase inhibitor infusion
por: Igonin, A, et al.
Publicado: (2009)

Surviving ratio of severe sepsis treated with activated protein C in one university intensive care unit during 2003–2006
por: Tokarz, A, et al.
Publicado: (2007)

Effect of including procalcitonin and C-reactive protein in the Mortality in Emergency Department Sepsis risk prediction model
por: Lee, C, et al.
Publicado: (2011)

C1-esterase inhibitor (C1INH) implication in systemic inflammation in sepsis
por: Igonin, A, et al.
Publicado: (2010)

Daily assay of procalcitonin, C-reactive protein and IL-6 roles in diagnosis and management of severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

Sepsis in neonates: experience in a tertiary-care hospital
por: Guerrero-Lozano, I, et al.
Publicado: (2012)

Clinical experience with lipopolysaccharide adsorber in cancer patients with severe sepsis and septic shock
por: Gromova, E, et al.
Publicado: (2010)

Clinical utility of using C-reactive protein and procalcitonin as biomarkers for a novel neonatal sepsis diagnostic platform (ASCMicroPlat)
por: McAllister, K, et al.
Publicado: (2012)

Influence of CYP3A5 polymorphism on tacrolimus drug dosing in Indian renal allograft recipients: initial experience
por: Patel, Mohan, et al.
Publicado: (2014)

Differentiating sepsis from non-infective systemic inflammatory response syndrome: comparison between C-reactive protein and leptin
por: Farag, N, et al.
Publicado: (2014)

C-reactive protein ratio response patterns in pediatric sepsis: a cohort study - preliminary results
por: Soares Lanziotti, V, et al.
Publicado: (2015)

AMP-activated protein kinase preserves endothelial tight junctions in the coronary microcirculation during sepsis
por: Castanares-Zapatero, D, et al.
Publicado: (2012)

Are we feeding our critically ill patients appropriately?
por: Ramakrishnan, N, et al.
Publicado: (2010)

Cell-culture model to study endothelial activation in sepsis
por: Eichhorn, T, et al.
Publicado: (2015)

Age and number of organ dysfunctions are associated with early mortality in patients suffering from severe sepsis treated with recombinant human activated protein C
por: Vazquez de Anda, G, et al.
Publicado: (2004)

Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008)

Activated protein C: cost matters!
por: Dravid, T, et al.
Publicado: (2010)

0099. Nitrite reductase activity during sepsis
por: Simon, V, et al.
Publicado: (2014)

The effect of activated protein C on experimental acute necrotizing pancreatitis
por: Yamanel, L, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g23akcb68b2phqu8f2l120t13h